Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972109 · ClinicalTrials.gov registry record · NA
Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling
A NA study of Insulin Sensitivity and Obesity, Abdominal, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 604
- Enrollment target
- 1
- Study location
NCT05972109 is a NA study of Insulin Sensitivity and Obesity, Abdominal that has completed, run by University of California, San Francisco. The registered enrollment target is 604 participants, above the 52-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (1062% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05972109, a NA study of Insulin Sensitivity and Obesity, Abdominal, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 604 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to test the impact of a multilevel workplace intervention (hospital-wide sales ban on sugar-sweetened beverages (SSBs) and individual-level brief counseling) on employee health.
Conditions Studied
Interventions
- BEHAVIORAL Brief Intervention
- OTHER Workplace SSB sales ban
Study Locations (1)
California
- Sutter Health/California Pacific Medical Center Research Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 604 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05972109
The ClinicalTrials.gov registry entry for NCT05972109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 604 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 52-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (1062% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Insulin Sensitivity appearing as the primary indexed condition, and to 2 interventions - of which Brief Intervention is the first listed.
NCT05972109 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05972109 about?
NCT05972109 is a clinical study titled "Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling". The purpose of the study is to test the impact of a multilevel workplace intervention (hospital-wide sales ban on sugar-sweetened beverages (SSBs) and individual-level brief counseling) on employee health.
What is the current status of trial NCT05972109?
This trial is currently completed. It is a NA study. The enrollment target is 604 participants. The study started on 2023-08-01. Estimated completion is 2026-02-01.
What conditions does trial NCT05972109 study?
This clinical trial studies the following conditions: Insulin Sensitivity, Obesity, Abdominal.
What interventions are being tested in trial NCT05972109?
The interventions under investigation include: Brief Intervention (BEHAVIORAL), Workplace SSB sales ban (OTHER).
Who is sponsoring clinical trial NCT05972109?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05972109 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Countermeasures to Circadian Misalignment
RECRUITING · NA
-
Effect of Pulsatile Hormone Administration on Insulin Action
RECRUITING · NA
-
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
RECRUITING · NA
-
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.